✦ LIBER ✦

CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies

✍ Scribed by Stephen A. Beers; Claude H.T. Chan; Ruth R. French; Mark S. Cragg; Martin J. Glennie

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MONOCLONAL ANTIBODIES AS TARGETING AND T

✍ John M Luk; Kwong-Fai Wong 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Endothelium as a target for anti-phospho

✍ Pier Luigi Meroni; Elena Raschi; Cinzia Testoni 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 284 KB

204 POSTER Discovery and validation of a

✍ J. Papkoff; A. Strelow; S. Lee; A. Nguyen; G. Diedrich; S. Zhuo; W. Liu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A one-step monoclonal antibody typing pr

✍ Jar-How Lee; Mamie Lias; Chun-Tsan Deng; Soudabeh Etessami; Jimmy Loon; Mike Che 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

Glucagon antagonism as a potential thera

✍ J. I. Bagger; F. K. Knop; J. J. Holst; T. Vilsbøll 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Rituximab (anti-CD20 monoclonal antibody

✍ Gerald Jäeger; Peter Neumeister; Ruth Brezinschek; Gerald Höfler; Franz Quehenbe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB